Felix Fischbach

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data.

Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 25, 2025

Treatment of neuroimmunological diseases with chimeric antigen receptor (CAR) T cells : Experience and new developments

Treatment of neuroimmunological diseases with chimeric antigen receptor (CAR) T cells : Experience and new developments

Journal: Zeitschrift fur Rheumatologie

Published: June 01, 2025

Comparison of anti-human T cell globulins on immune reconstitution and early infections after autologous transplant in patients with multiple sclerosis.

Comparison of anti-human T cell globulins on immune reconstitution and early infections after autologous transplant in patients with multiple sclerosis.

Journal: Bone marrow transplantation

Published: April 29, 2025

A GDF-15-GFRAL axis controls autoimmune T cell responses during neuroinflammation.

A GDF-15-GFRAL axis controls autoimmune T cell responses during neuroinflammation.

Journal: Nature immunology

Published: March 09, 2025

Intracellular complement factor H protects neurons during CNS inflammation.

Intracellular complement factor H protects neurons during CNS inflammation.

Journal: Nature

Published: February 08, 2025

Current state and perspectives of CAR T cell therapy in central nervous system diseases.

Current state and perspectives of CAR T cell therapy in central nervous system diseases.

Journal: Brain : a journal of neurology

Published: July 19, 2024

Exploring the therapeutic potential of autologous hematopoietic stem cell transplantation in progressive multiple sclerosis-a systematic review.

Exploring the therapeutic potential of autologous hematopoietic stem cell transplantation in progressive multiple sclerosis-a systematic review.

Journal: European journal of neurology

Published: May 24, 2024

"A second birthday"? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation-a qualitative interview study.

"A second birthday"? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation-a qualitative interview study.

Journal: Frontiers in neurology

Published: February 09, 2024

CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis.

CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis.

Journal: Med (New York, N.Y.)

Published: January 04, 2024

Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life.

Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life.

Journal: Multiple sclerosis and related disorders

Published: November 13, 2023

History of cerebrovascular disease but not dementia increases the risk for secondary vascular events during SARS-CoV-2 infection with presumed Omicron variant: a retrospective observational study.

History of cerebrovascular disease but not dementia increases the risk for secondary vascular events during SARS-CoV-2 infection with presumed Omicron variant: a retrospective observational study.

Journal: European journal of neurology

Published: February 20, 2023

Case series of idiopathic intracranial hypertension in three patients with immune-complex glomerulonephritis.

Case series of idiopathic intracranial hypertension in three patients with immune-complex glomerulonephritis.

Journal: BMC neurology

Published: November 26, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026